Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 806, pseudogene (RNU6-806P) is a transcribed pseudogene related to U6 small nuclear RNA (snRNA) genes, which play a central role in the major spliceosome complex of the eukaryotic nucleus by facilitating intron removal from pre-mRNA[2][4][5]. Pseudogenes like RNU6-806P are non-coding genomic sequences that share homology with functional RNA genes but are generally considered nonfunctional and are not translated into protein[2][4][5]. The U6 snRNA family itself is highly conserved and essential for splicing, but RNU6-806P represents a processed, likely inactive copy within the genome[5]. There are no reported direct biological functions, disease associations, or known interactions with drugs for this specific pseudogene variant[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 806, pseudogene (RNU6-806P).